Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads In Hematology
Hematology for January/February 2019
Venous Thromboembolism Risk in US Hospitals, Am J Med; ePub 2019 Jan 16; Huang, et al
Hematology for September/October 2018
Phase 3 data on emicizumab, Mahlangu et al. N Engl J Med. 2018;379:811-22
Integrated programs ease sickle cell pain, hospitalizations, Annual meeting of the Foundation for Sickle Cell Disease Research
Watch for RBC adhesion in men with sickle cell , Annual meeting of the Foundation for Sickle Cell Disease Research
Leukemia risk after maternal contraception use, Hargreave M et al. Lancet Oncol. 2018 Sep 6. doi: 10.1016/S1470-2045(18)30479-0
Hematology for May/June 2018
Trends in DVT Hospitalization Rates in Older Adults, Am J Med; ePub 2018 May 10; Minges, et al
Hematology for July/August 2017
Is Idarucizumab Safe for Dabigatran Reversal?, N Engl J Med; 2017 Aug 3; Pollack, et al
Hematology for January/February 2017
Sickle Cell Trait & HbA1c in African Americans, JAMA; 2017 Feb 7; Lacy, Wellenius, et al